Publikation: Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Fas (CD95/APO-1) ligand (FasL)-mediated cytotoxicity has been implicated in tissue destruction in a variety of diseases, including acute graft-vs-host disease (GVHD). In this study, we have analyzed FasL expression and regulation during the course of experimental murine acute GVHD. Although activation-induced FasL-mediated cytotoxicity in control T cells was sensitive to the immunosuppressant cyclosporin A, we observed that functional FasL expression of GVHD T cells became increasingly cyclosporin A unresponsive. This was found to be the result of a massive in vivo accumulation and intracellular storage of FasL protein and its release in a transcription- and protein synthesis-independent manner. Immunohistochemistry analysis of FasL expression in situ revealed accumulation of FasL-expressing cells in the spleen, the liver, and small intestine, with a typical cytoplasmic and granular expression pattern. Thus, we conclude that the release of preformed FasL by infiltrating donor T cells may contribute to recipient tissue damage during the pathogenesis of acute GVHD.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
WASEM, Christoph, Corina FRUTSCHI, Diana ARNOLD, Claudio VALLAN, Tesu LIN, Douglas R. GREEN, Christoph MUELLER, Thomas BRUNNER, 2001. Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease. In: Journal of Immunology. 2001, 167(5), pp. 2936-2941. ISSN 0022-1767. eISSN 1550-6606. Available under: doi: 10.4049/jimmunol.167.5.2936BibTex
@article{Wasem2001Accum-14295, year={2001}, doi={10.4049/jimmunol.167.5.2936}, title={Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease}, number={5}, volume={167}, issn={0022-1767}, journal={Journal of Immunology}, pages={2936--2941}, author={Wasem, Christoph and Frutschi, Corina and Arnold, Diana and Vallan, Claudio and Lin, Tesu and Green, Douglas R. and Mueller, Christoph and Brunner, Thomas} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14295"> <dc:contributor>Lin, Tesu</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14295"/> <dc:creator>Arnold, Diana</dc:creator> <dc:creator>Vallan, Claudio</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Wasem, Christoph</dc:creator> <dc:contributor>Arnold, Diana</dc:contributor> <dc:creator>Frutschi, Corina</dc:creator> <dc:contributor>Green, Douglas R.</dc:contributor> <dc:contributor>Frutschi, Corina</dc:contributor> <dc:creator>Mueller, Christoph</dc:creator> <dc:language>eng</dc:language> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14295/2/2001_Wasem_Accumulation.pdf"/> <dcterms:abstract xml:lang="eng">Fas (CD95/APO-1) ligand (FasL)-mediated cytotoxicity has been implicated in tissue destruction in a variety of diseases, including acute graft-vs-host disease (GVHD). In this study, we have analyzed FasL expression and regulation during the course of experimental murine acute GVHD. Although activation-induced FasL-mediated cytotoxicity in control T cells was sensitive to the immunosuppressant cyclosporin A, we observed that functional FasL expression of GVHD T cells became increasingly cyclosporin A unresponsive. This was found to be the result of a massive in vivo accumulation and intracellular storage of FasL protein and its release in a transcription- and protein synthesis-independent manner. Immunohistochemistry analysis of FasL expression in situ revealed accumulation of FasL-expressing cells in the spleen, the liver, and small intestine, with a typical cytoplasmic and granular expression pattern. Thus, we conclude that the release of preformed FasL by infiltrating donor T cells may contribute to recipient tissue damage during the pathogenesis of acute GVHD.</dcterms:abstract> <dc:creator>Lin, Tesu</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14295/2/2001_Wasem_Accumulation.pdf"/> <dc:contributor>Mueller, Christoph</dc:contributor> <dc:creator>Brunner, Thomas</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-21T12:42:22Z</dcterms:available> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-21T12:42:22Z</dc:date> <dcterms:title>Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease</dcterms:title> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Vallan, Claudio</dc:contributor> <dc:creator>Green, Douglas R.</dc:creator> <dc:contributor>Wasem, Christoph</dc:contributor> <dcterms:bibliographicCitation>First publ. in: Journal of Immunology ; 167 (2001), 5. - S. 2936-2941</dcterms:bibliographicCitation> <dc:rights>terms-of-use</dc:rights> <dc:contributor>Brunner, Thomas</dc:contributor> <dcterms:issued>2001</dcterms:issued> </rdf:Description> </rdf:RDF>